
Professor Trevor Chong
Professor Trevor Chong is a leading researcher at the Melbourne-based Turner Institute for Brain and Mental Health, where he studies Alzheimer’s treatments, including the new drug donanemab, which has shown promise in slowing cognitive decline in patients with early Alzheimer’s.
Power538
Reach12,365
Country presence
Recent news mentions
Professor Trevor Chong discusses the limited impact of new Alzheimer’s drugs for Australians.
With new blood tests for Alzheimer’s and next-gen drugs that may slow its progression, is there hope at last?The New Zealand Herald – country’s largest newspaper, est. 1863·
New Zealand· 2026-06-02






